UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Roles and Regulation of BCL-xL in Hematological Malignancies

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2193

2022

Volltextzugriff (PDF)

Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9091

2022

Volltextzugriff (PDF)

p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy

Cancers, 2024-01, Vol.16 (2), p.256

2024

Volltextzugriff (PDF)

Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells

Food and chemical toxicology, 2017-02, Vol.100, p.90-102

2017

Volltextzugriff (PDF)

MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1

Frontiers in oncology, 2020-10, Vol.10, p.588893-588893

2020

Volltextzugriff (PDF)

Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene

Leukemia & lymphoma, 2018-11, Vol.59 (11), p.2628-2638

2018

Volltextzugriff (PDF)

Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases

Nitric oxide, 2008-09, Vol.19 (2), p.152-157

2008

Volltextzugriff (PDF)

Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (19), p.7117-7126

2004

Volltextzugriff (PDF)

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

Clinical cancer research, 2009-11, Vol.15 (21), p.6582-6594

2009

Volltextzugriff (PDF)

Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis

Cell cycle (Georgetown, Tex.), 2011-08, Vol.10 (16), p.2792-2805

2011

Volltextzugriff (PDF)

Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis

Oncogene, 2005-12, Vol.24 (55), p.8114-8127

2005

Volltextzugriff (PDF)

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance

Oncogene, 2004-04, Vol.23 (20), p.3530-3540

2004

Volltextzugriff (PDF)

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation

Respiratory research, 2012-07, Vol.13 (1), p.60-60, Article 60

2012

Volltextzugriff (PDF)

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival

BMC cancer, 2011-06, Vol.11 (1), p.259-259, Article 259

2011

Volltextzugriff (PDF)

KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent

Leukemia & lymphoma, 2021-05, Vol.62 (6), p.1422-1431

2021

Volltextzugriff (PDF)

Function of Deptor and its roles in hematological malignancies

Aging (Albany, NY.), 2021-01, Vol.13 (1), p.1528-1564

2021

Volltextzugriff (PDF)

Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (3), p.1270-1281

2007

Volltextzugriff (PDF)

A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity

Molecular cancer therapeutics, 2019-10, Vol.18 (10), p.1822-1831

2019

Volltextzugriff (PDF)

Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation

Leukemia & lymphoma, 2019-03, Vol.60 (4), p.1062-1070

2019

Volltextzugriff (PDF)

Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma

Oncotarget, 2019-03, Vol.10 (22), p.2173-2188

2019

Volltextzugriff (PDF)

Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer

Nitric oxide, 2013-02, Vol.29, p.17-24

2013

Volltextzugriff (PDF)

Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively

The Journal of immunology (1950), 2005-08, Vol.175 (4), p.2174-2183

2005

Volltextzugriff (PDF)

Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy

International journal of oncology, 2015-11, Vol.47 (5), p.1735-1748

2015

Volltextzugriff (PDF)

Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic target

Future microbiology, 2018-06, Vol.13 (7), p.785-798

2018

Volltextzugriff (PDF)

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

BMC cancer, 2015-10, Vol.15 (1), p.722, Article 722

2015

Volltextzugriff (PDF)

1 – 25 von 1.320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.084)
Mit Volltextzugriff
(1.112)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(32)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Roles and Regulation of BCL-xL in Hematological Malignancies

Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology

p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy

Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells

MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1

Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene

Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases

Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis

Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival

KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent

Function of Deptor and its roles in hematological malignancies

Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy

A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity

Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation

Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma

Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer

Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively

Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy

Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic target

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

Suchergebnisse filtern